Date Title Description PDF
03 Nov 2021 On buy-back programmes The Company reports the commencement, effective as of today, 3 November 2021, of a share buyback program. Download
16 Jul 2021 On Corporate Governance ROVI announces the appointment of Juan López-Belmonte Encina as Chairman of the Company   Download
22 Jun 2021 On significant placements in financial instruments Bestinver announces the beginning of an accelerated book build process of up to a 3% of the share capital of Laboratorios Rovi, S.A. Download
22 Jun 2021 On significant placements in financial instruments Hereby inform of the completion of the private placement package. The amount of the Placement amounted to a total of 87.88 million euros, being the unit selling price of 52.25 euros per share. Download
29 Apr 2021 On business and financial situation The Company informs about the increase of its fill-finish capacity for the manufacture of Moderna’s COVID-19 vaccine outside the United States.     Download

Pages

Date Title Description PDF
26 Jun 2023 Other relevant information The Company informs about the dividends payment Download
14 Jun 2023 Announcement of general shareholders’ meeting ROVI releases the information related to its General Shareholders Meeting. Download
31 May 2023 Other relevant information ROVI informs about the news items that have appeared in several media today regarding ROVI’s receipt of government grants Download
10 May 2023 Announcement of General Shareholders’ Meeting ROVI releases the information related to its General Shareholders Meeting Download
10 Apr 2023 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the first quarter of 2023 Download

Pages

Date Title Description PDF
07 Nov 2013 Información sobre resultados (2) Download
06 Nov 2013 Información sobre resultados Download
31 Jul 2013 Información sobre resultados Download
31 Jul 2013 Información sobre resultados (2) Download
01 Jul 2013 Información sobre dividendos Download

Pages